
the staff of the Ridgewood blog
West Orange NJ, RWJBarnabas Health is proud to have been a participant in one of the Gilead trials to assess antiviral Remdesivir as a treatment for patients with severe COVID-19. Gilead recently announced promising top line results that show similar efficacy with 5- and 10- day dosing durations of the drug.